The PI3K/Akt signaling pathway was first identified by Professor Cantley from Weill Cornell Medical College in the USA, and its function in cancer progression was first introduced.[14] This indicates that the People’s Republic of China dominates studies on the PI3K/Akt signaling pathway in OA. The gene discussed is AKT1; the disease is cancer.